177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

NCT06395402 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors
Neuroendocrine Tumor Grade 1
Neuroendocrine Tumor Grade 2

Interventions

DRUG: Lutetium Lu 177 dotatate therapy

Sponsor

University of Iowa

Collaborators

[object Object]